Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

HEALTH

The Claim

The International Council for Harmonisation (ICH) and the United States Pharmacopeia (USP) have published guidelines regarding the control and limits of pharmaceutical impurities as of April 16, 2026.

Verified by Lenz ·

The Short Version

Both ICH and USP have demonstrably published guidelines addressing the control and limits of pharmaceutical impurities well before April 16, 2026. ICH's Q3A(R2), Q3B(R2), Q3C, and Q3D(R2) guidelines establish specific thresholds for organic, solvent, and elemental impurities, confirmed by primary ICH and EMA sources. USP has published compendial chapters including <232> on elemental impurity limits and <233> on procedures, with <233> published in April 2025 though becoming officially enforceable May 1, 2026. The claim accurately reflects the published status of these guidelines.

Caveats

  • USP General Chapter <233> was published April 25, 2025 but does not become officially enforceable until May 1, 2026 — slightly after the claim's reference date — though it qualifies as 'published' in the sense of being publicly available.
  • The available evidence primarily documents USP's elemental impurity chapters (<232>/<233>); USP's published guidance on other impurity categories (e.g., organic impurities, residual solvents) is less explicitly represented in the evidence pool, though chapters like <1086> exist.
  • ICH guidelines are internationally harmonized recommendations, while USP chapters are compendial standards with legal force in the US — the claim does not distinguish between these different regulatory mechanisms.

The Receipts

  1. Quality Guidelines - ICH

    ICH

  2. Impurities in new drug substances Q3A (R2) - Guideline

    ICH (International Council for Harmonisation)

  3. Guideline for Elemental Impurities Q3D(R2)

    ICH (International Council for Harmonisation)

  4. ICH Q 3 B (R2) Impurities in New Drug Products - Step 5

    European Medicines Agency (EMA)

  5. Elemental Impurities—Procedures - US Pharmacopeia (USP)

    US Pharmacopeia (USP)

  6. Elemental Impurities Updates | USP

    USP

  7. Recent trends in the impurity profile of pharmaceuticals - PMC

    PMC

  8. USP Revamps Drug Purity Rules - Drug Delivery Summit 2026

    Drug Delivery Summit 2026

  9. 资源分享-EMA-Reflection Paper on the qualification of non ...

    pharmlibrary.com

  10. Elemental impurities in Pharmaceutical Materials according to new ICH Guidelines and USP Chapters 232 and 233

    Analytik Jena

+ 14 more sources — see the full list on Lenz

Filed Under

International Council for Harmonisationpharmaceutical impuritiesUnited States Pharmacopeia